Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
Característiques principals
Topics of the 10th Call:
  • Topic 1: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials
  • Topic 2: How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes programme)
  • Topic 3: Improving the care of patients suffering from acute or chronic pain (this topic includes three subtopics on patient reported outcomes; biomarkers; and chronic pelvic pain)
  • Topic 4: Creation of a pan-European paediatric clinical trials network
  • Topic 5: Biomanufacturing 2020: development of innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes
  • Topic 6: Unlocking the solute carrier gene-family for effective new therapies (unlock SLCs)
  • Topic 7: Patient perspectives in medicines lifecycle
  • Topic 8: Personalised medicine approaches in autism spectrum disorders
    • Característiques principals
    This Call is being run in a two stage submission and evaluation process.
    Short proposals for this call can only be done through the Horizon 2020 Participant Portal:
    http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/h2020-jti-imi2-2016-10-two-stage.html
    Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    • Carol Barnwell, cbarnwell@imim.es. Ext.: 1670
    • Marta López, mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    http://www.imi.europa.eu/content/imi-2-call-10
    Dotació
    IMI JU collaborative projects are implemented through a co-financing scheme. The IMI JU grants financial support to the eligible entities, while the other entities (including the EFPIA companies) participate in the project with their own resources.
    The EU contribution is:
  • Topic 1: 13 460 000 EUR
  • Topic 2: 6 000 000 EUR
  • Topic 3A: 4 250 000 EUR / 3B: 4 140 000 EUR / 3C: 2 840 000 EUR
  • Topic 4: 67 000 000 EUR
  • Topic 5: 4 700 000 EUR
  • Topic 6: 12 000 000 EUR
  • Topic 7: 4 500 000 EUR
  • Topic 8: 55 000 000 EUR
    • AVÍS IMPORTANT
    During December, IMI held webinars on all IMI 2 – Call 10 topics as well as IMI’s rules and procedures. The presentations from, and recordings of, all IMI 2 – Call 10 webinars can be found on the webinar page: http://www.imi.europa.eu/events/2016/11/28/webinars-imi-2-call-10

    Arxius

    Arxiu
    IMI2_Call10_TopicsText.pdf